These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 19059832)
21. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948 [TBL] [Abstract][Full Text] [Related]
22. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis. Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416 [TBL] [Abstract][Full Text] [Related]
23. Critical role for c-FLIP(L) on Fas resistance in colon carcinoma cell line HT-29. Zang F; Sun B; Zhao X; Niu R; Zhang S; Yu M; Wei X; Zhang L Cell Biol Int; 2008 Mar; 32(3):329-36. PubMed ID: 18243739 [TBL] [Abstract][Full Text] [Related]
24. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Peltonen S; Riehokainen J; Pummi K; Peltonen J Br J Dermatol; 2007 Mar; 156(3):466-72. PubMed ID: 17300235 [TBL] [Abstract][Full Text] [Related]
25. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production. Wei L; Debets R; Hegmans JJ; Benner R; Prens EP J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092 [TBL] [Abstract][Full Text] [Related]
26. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin. Yu H; Mrowietz U; Seifert O Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145 [TBL] [Abstract][Full Text] [Related]
27. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis. El-Domyati M; Moftah NH; Nasif GA; Abdel-Wahab HM; Barakat MT; Abdel-Aziz RT Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):18-26. PubMed ID: 23281693 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-1: a key inflammatory mediator in psoriasis? Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958 [TBL] [Abstract][Full Text] [Related]
30. Increased expression of interleukin-4 receptors on psoriatic epidermal cells. Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. Abdou AG; Hanout HM J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174 [TBL] [Abstract][Full Text] [Related]
32. Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin. Karlsson T; Rollman O; Vahlquist A; Törmä H Acta Derm Venereol; 2004; 84(5):363-9. PubMed ID: 15370702 [TBL] [Abstract][Full Text] [Related]
33. Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes. Oyama N; Takahashi H; Tojo M; Iwatsuki K; Iizuka H; Nakamura K; Homma Y; Kaneko F Arch Dermatol Res; 2002 Aug; 294(6):273-80. PubMed ID: 12192491 [TBL] [Abstract][Full Text] [Related]
34. Altered morphology and distribution of cellular junction proteins in non-lesional psoriatic epidermis: an insight into disease severity. Lemini-López A; Flores-Romo L; Arévalo-López A; Meza I Arch Med Res; 2006 Jan; 37(1):36-44. PubMed ID: 16314184 [TBL] [Abstract][Full Text] [Related]
35. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis. Bhawan J; Bansal C; Whren K; Schwertschlag U; J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676 [TBL] [Abstract][Full Text] [Related]
36. Adducin expression in cutaneous and oral lesions: alpha- and beta-adducin transcripts down-regulate with keratinocyte differentiation in stratified epithelia. Bowen SL; Bloor BK; Leigh IM; Waseem A J Pathol; 2003 Sep; 201(1):119-26. PubMed ID: 12950024 [TBL] [Abstract][Full Text] [Related]
37. Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis. Peternel S; Prpić-Massari L; Manestar-Blažić T; Brajac I; Kaštelan M Arch Dermatol Res; 2011 Aug; 303(6):389-97. PubMed ID: 21279373 [TBL] [Abstract][Full Text] [Related]
38. HOXB4 homeodomain protein is expressed in developing epidermis and skin disorders and modulates keratinocyte proliferation. Kömüves LG; Michael E; Arbeit JM; Ma XK; Kwong A; Stelnicki E; Rozenfeld S; Morimune M; Yu QC; Largman C Dev Dyn; 2002 May; 224(1):58-68. PubMed ID: 11984874 [TBL] [Abstract][Full Text] [Related]
39. [Expression of E-cadherin, beta-catenin and cyclin D1 in epidermal skin lesions of patients with active psoriasis vulgaris]. Li ZX; Ji FP; Peng ZH; Wang K Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):545-7. PubMed ID: 18495586 [TBL] [Abstract][Full Text] [Related]
40. The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Thorslund K; El-Nour H; Nordlind K Arch Dermatol Res; 2009 Jul; 301(6):449-57. PubMed ID: 19263059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]